Skip to main content
. 2021 Nov 13;43(3):2011–2021. doi: 10.3390/cimb43030138

Figure 3.

Figure 3

Behavioral and electrophysiological enhancements in farnesol-administered mice. (A) Experimental scheme of farnesol administration to C22 mice. C22 mice were fed AIN-76A diet containing 0.5% (w/w) farnesol (C22-FSN, n = 10) or AIN-76A diet (C22-Con, n = 10) from 3 weeks of age. Age-matched wild-type mice (n = 10) were used as a reference (B) Rotarod test was performed to evaluate locomotor function. (C) Representative images of electrophysiological evaluation. (D) motor nerve conduction velocity (MNCV). (E) Compound muscle action potential (CMAP). WT, wild-type mice; C22-Con, control diet fed C22 mice; C22-FNS, farnesol diet fed C22 mice; * p < 0.05; and ***, p < 0.001.